Drawing for NUMARK

USPTO serial 75696937

NUMARK

Reviewed by CopyMark Law Group

Reg. 2399434Status 800Registered
Filing date
Status date
Registration date
Oct 31, 2000
Examiner
JENKINS JR, CHARLES L
Law office
TMEG LAW OFFICE 105

What this means

Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with NUMARK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Todd A. Denys

Todd A. Denys Porzio, Bromberg & Newman, P.C.600 ALEXANDER ROAD, SUITE 2-1PRINCETON, NJ 08540UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001SACCHARINSECTION 8 - CANCELLED—
003HOUSE MARK FOR A COMPLETE LINE OF BEAUTY CARE PRODUCTS, NAMELY, ANTIPERSPIRANTS AND DEODORANTS; MOUTHWASH; NON-MEDICATED MOUTHWASH AND GARGLE; FOR USE GENERALLY IN WET DRESSINGS AND WET PACKS; [ TOOTHPASTE; ] SKIN CREAM CONTAINING LANOLIN OIL; SOAP; SKIN CARE FOR THE CARE AND CLEANSING OF THE SKIN; [ COSMETIC AND FACIAL SKIN CLEANING PREPARATIONS AND ] COSMETIC MOISTURIZING LOTIONACTIVE—
005HOUSEMARK FOR A COMPLETE LINE OF PHARMACEUTICAL AND HERBAL REMEDIES, NAMELY, PREPARATIONS FOR USE AS A DENTAL ANTISEPTIC AND LOCAL ANALGESIC; PREPARATIONS FOR THE TREATMENT OF PYORRHEA; PREPARATIONS FOR USE AS A WET DRESSING IN ORAL SURGERY IN WHICH ANTISEPTIC OR ASTRINGENT ACTION IS DESIRED; [ MEDICATED THROAT SPRAY; NASAL SPRAY; ] MEDICATED PREPARATIONS FOR APPLICATION TO THE EAR, EYE, TONSILS, LARYNX, PHARYNX, RECTUM, BLADDER, PELVIS, VAGINAL CERVIX, UTERUS AND SKIN; MEDICATED PREPARATIONS FOR THE TREATMENT OF SCALDS AND FOR GENERAL TOPICAL APPLICATION; PREPARATIONS FOR USE AS ANTISEPTIC SOLUTIONS; PREPARATIONS FOR USE AS ASTRINGENTS; VITAMIN, MINERAL AND HERBAL PREPARATIONS USED AS A NUTRITIONAL SUPPLEMENT AND TO TREAT DISORDERS AND IRREGULARITIES ASSOCIATED WITH MENSTRUATION AND MENOPAUSE; [ TOPICAL ANTIBIOTIC AND ANESTHETIC PHARMACEUTICAL PREPARATIONS; ] MEDICATED ANTISEPTIC POWDER; [ INHALANT SOLUTION COMPOSED PRINCIPALLY OF EPINEPHRINE HYDROCHLORIDE USED IN THE TREATMENT OF ASTHMA; MEDICINES FOR BLADDER AND KIDNEY DISORDERS; LIPOTROPIC FLAVONOID PREPARATIONS; ] LAXATIVES; [ PHARMACEUTICAL PREPARATION FOR TEMPORARY RELIEF FROM ACUTE PAROXYSMS OF BRONCHIAL ASTHMA; ] OINTMENT FOR THE CONTROL OF ACNE; SALINE TABLET FOR MEDICINAL USE; LIPOTROPIC-OXYTROPIC PREPARATION FOR USE AS A VITAMIN DIETARY SUPPLEMENT; PREPARATIONS HAVING ALTERNATIVE, ANTISEPTIC, CLEANSING, DEODORIZING, DIURETIC, LAXATIVE, TONIC, AND SEDATIVE PROPERTIES AND INDICATED IN AND FOR THE TREATMENT OF CHLOROSIS, CONSTIPATION, FUNCTIONAL DISORDERS AND IRREGULARITIES OF THE MENSES, LIVER COMPLAINTS, AND OTHER PHYSICAL DISORDERS AND PATHOLOGICAL CONDITIONS; PHARMACEUTICAL PREPARATIONS, namely, A CONSTIPATION OR DIARRHEA STOOL NORMALIZER; [ ETHICAL PHARMACEUTICAL PREPARATION FOR USE AS ANTITUSSIVE, ANTIHISTAMINIC, DECONGESTANT EXPECTORANT; ETHICAL PHARMACEUTICAL PREPARATION AS AN AID IN THE TREATMENT OF OBESITY; ANTIHISTAMINE; VASOCONSTRICTOR AND DECONGESTANT PREPARATION; ] PHARMACEUTICAL PREPARATION, namely, AN OINTMENT COMPRISED OF [ BORACIC ACID, ] ZINC OXIDE, EUCALYPTOL, [ PREPARED SUET ] AND PETROLATUM, INDICATED FOR USE WHEREVER AN ASTRINGENT, NON-IRRITATING AND SMOOTH OINTMENT DRESSING IS REQUIRED, TO PROTECT AND SOFTEN ABRADED OR INJURED SURFACE TISSUE, SUCH AS OCCURS IN ECZEMA, HEMORRHOIDS, ULCERS, SCALDS, BURNS, SUNBURNS, AND SURFACE WOUNDS OR ABRASIONS; [ EFFERVESCENT SALT, SOLD IN GRANULAR OR TABLET FORM, FOR SIMPLE HEADACHE AND NEURALGIA; DEODORANT TABLET FOR INTERNAL ADMINISTRATION; PLASTERS, HEADACHE POWDERS; A REMEDY MADE MAINLY OF HERBS FOR THE CURE OF OBESITY; A MEDICINE MADE MAINLY OF HERBS IN THE FORM OF A TEA FOR THE CURE OF CONSTIPATION, LIVER AND KIDNEY DISEASES; PHARMACEUTICAL PREPARATIONS FOR RESPIRATORY THERAPY ]ACTIVE—
010[MEDICAL APPARATUS, NAMELY, A NEBULIZER FOR USE DISPENSING INHALANT SOLUTIONS FOR RESPIRATORY THERAPY; DENTURE RELINE KIT FOR PERSONAL USE OF DENTURE WEARERS COMPRISED OF A LIQUID METHYLMETHACRYLATE MONOMER WITH A RETARDING AGENT AND POWDER METHYLMETHACRYLATE POLYMER WITH A RETARDING AGENT; DENTURE REPAIR KIT FOR PERSONAL USE OF DENTURE WEARERS COMPRISED OF A LIQUID METHYLMETHACRYLATE MONOMER AND APPLIED TO BREAKS AND CRACKS ON DENTURES]SECTION 8 - CANCELLED—
034[CIGARETTE FILTERS]SECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 29, 2021NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Jan 29, 2021RNL2REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Jan 29, 20219G8PREGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8—
Jan 29, 20218PRTREGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED—
Jan 24, 2021APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 2, 2020E89RTEAS SECTION 8 & 9 RECEIVED—
Oct 31, 2019REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Nov 29, 2017ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jul 12, 2017ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Aug 24, 2016ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Feb 4, 2015ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jan 19, 2010RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Jan 19, 201089AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Jan 15, 2010E89RTEAS SECTION 8 & 9 RECEIVED—
May 15, 2007C15PREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jan 5, 2007PLGLASSIGNED TO PARALEGAL—
Nov 2, 2006815FREGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED—
Nov 2, 2006MAILPAPER RECEIVED—
Aug 8, 2006CFITCASE FILE IN TICRS—
Oct 31, 2000R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 8, 2000PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 7, 2000NPUBNOTICE OF PUBLICATION—
May 8, 2000CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 24, 2000CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 30, 1999CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 27, 1999DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance